First do no harm - Improving drug safety through legislation and independent research

被引:13
作者
Greener, Mark
机构
关键词
D O I
10.1038/embor.2008.17
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:221 / U1
页数:4
相关论文
共 10 条
[1]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[2]  
*EMEA, 2007, QU ANSW BEN RISKS RO
[3]   Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial [J].
Farkouh, ME ;
Kirshner, H ;
Harrington, RA ;
Ruland, S ;
Verheugt, FW ;
Schnitzer, T ;
Burmester, GR ;
Mysler, E ;
Hochberg, MC ;
Doherty, M ;
Ehrsam, E ;
Gitton, X ;
Krammer, G ;
Mellein, B ;
Gimona, A ;
Matchaba, P ;
Hawkey, CJ ;
Chesebro, JH .
LANCET, 2004, 364 (9435) :675-684
[5]   Case reports of suspected adverse drug reactions - systematic literature survey of follow-up [J].
Loke, YK ;
Price, D ;
Derry, S ;
Aronson, JK .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7537) :335-338E
[6]   Lessons from the avandia controversy [J].
Misbin, Robert I. .
DIABETES CARE, 2007, 30 (12) :3141-3144
[7]   Serious adverse drug events reported to the food and drug administration, 1998-2005 [J].
Moore, Thomas J. ;
Cohen, Michael R. ;
Furberg, Curt D. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (16) :1752-1759
[8]   Adverse effects of inhaled corticosteroids in funded and nonfunded studies [J].
Nieto, Antonio ;
Mazon, Angel ;
Pamies, Rafael ;
Linana, Juan J. ;
Lanuza, Amparo ;
Jimenez, Fernando Oliver ;
Medina-Hernandez, Alejandra ;
Nieto, F. Javier .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (19) :2047-2053
[9]   Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes (vol 356, pg 2457, 2007) [J].
Nissen, Steven E. ;
Wolski, Kathy .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2457-2471
[10]   Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial [J].
Schnitzer, TJ ;
Burmester, GR ;
Mysler, E ;
Hochberg, MC ;
Doherty, M ;
Ehrsam, E ;
Gitton, X ;
Krammer, G ;
Mellein, B ;
Matchaba, P ;
Gimona, A ;
Hawkey, CJ .
LANCET, 2004, 364 (9435) :665-674